Luye Pharma Group Ltd.'s Unit to Buy Two Biological Antibody Products

Aug 4 (Reuters) - Luye Pharma Group Ltd

* SHANDONG LUYE and Shandong Boan Biological Technology Co entered into asset transfer agreements

* Deal for a total consideration of rmb450 million, which is payable by stages.

MORE ON THIS TOPIC